May 8, 2018 / 12:24 PM / 5 months ago

BUZZ-Aralez Pharma: Sinks on going concern doubts, wider-than-expected loss

** Canadian drugmaker’s U.S.-listed shares plunge 20 pct to $1.21, second biggest decliner across U.S. exchanges in premarket

** Co raises substantial doubt about its ability to continue as a going concern due to liquidity issues

** As of March 31, co had cash and cash equivalents of about $43.9 million

** Posts a wider-than-expected Q1 loss; withdraws previous guidance

** Says to immediately wind down its U.S. commercial business and ultimately shut down U.S. operations; to focus on Canadian business

** U.S.-listed shares set to more that erase YTD gains of 7 pct; Canadian-listed shares rose ~8 pct YTD (Reporting by Shreyashi Sanyal in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below